Cambridge, MA
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
garudatx.comThese are collections Garuda Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$50,000,000
Series B
$62,000,000
Series A
$72,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Garuda Therapeutics.